Suppr超能文献

Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell.

作者信息

Ito Hiroyasu, Seishima Mitsuru

机构信息

Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, 1-1 Yanagido, Gifu City 501-1194, Japan.

出版信息

J Biomed Biotechnol. 2010;2010:641757. doi: 10.1155/2010/641757. Epub 2010 May 19.

Abstract

Cytotoxic T lymphocytes (CTLs) play a crucial role in the infections and the antitumor immunity. Induction and activation of antigen-specific CTLs is an important strategy in immunotherapy for various diseases, and several researchers have focused on the modulation of CTL induction and function. Natural killer T (NKT) cells are an important focus area of researchers studying immunomodulatory responses to tumors and infectious diseases. CD1d-restricted NKT cells consist of type I NKT cells and type II NKT cells. alpha-galactosylceramide (alpha-GalCer)-activated type I NKT cells secrete both Th1 (e.g., IFN-gamma) and Th2 cytokines, affect the expression of costimulatory molecules in immune cells, and regulate the host immune system. Type II NKT cells, however, are stimulated by sulfatide, a self-glycolipid derived from myelin, and play an immunosuppressive role in animal model of autoimmune diseases. CTL generation, activation, and suppression are strongly affected by activated type I and type II NKT cells. Thus, the regulation of these NKT cells leads to the modification of CTL function. CTLs contribute to antimicrobial responses, antitumor immune and autoimmune responses. Understanding the role of NKT cells in the regulation of CTL generation, activation, and suppression enable the development of novel treatment strategies for these diseases.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ed3/2873660/3b3f8ca7bd9d/JBB2010-641757.001.jpg

相似文献

1
Regulation of the induction and function of cytotoxic T lymphocytes by natural killer T cell.
J Biomed Biotechnol. 2010;2010:641757. doi: 10.1155/2010/641757. Epub 2010 May 19.
3
Natural killer T cell activation increases iNOSCD206 M1 macrophage and controls the growth of solid tumor.
J Immunother Cancer. 2019 Aug 6;7(1):208. doi: 10.1186/s40425-019-0697-7.
4
Ex vivo expanded human CD4+ regulatory NKT cells suppress expansion of tumor antigen-specific CTLs.
Int Immunol. 2005 Sep;17(9):1143-55. doi: 10.1093/intimm/dxh292. Epub 2005 Jul 18.
5
Tailored design of NKT-stimulatory glycolipids for polarization of immune responses.
J Biomed Sci. 2017 Mar 23;24(1):22. doi: 10.1186/s12929-017-0325-0.
6
Polyclonal type II natural killer T cells require PLZF and SAP for their development and contribute to CpG-mediated antitumor response.
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2674-9. doi: 10.1073/pnas.1323845111. Epub 2014 Feb 3.
7
Regulation of immune responses by CD1d-restricted natural killer T cells.
Immunol Res. 2004;30(2):139-53. doi: 10.1385/IR:30:2:139.
8
Glycolipid alpha-C-galactosylceramide is a distinct inducer of dendritic cell function during innate and adaptive immune responses of mice.
Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11252-7. doi: 10.1073/pnas.0604812103. Epub 2006 Jul 14.
9
Application of natural killer T cells in antitumor immunotherapy.
Crit Rev Immunol. 2007;27(6):511-25. doi: 10.1615/critrevimmunol.v27.i6.20.
10
Tissue-Specific Roles of NKT Cells in Tumor Immunity.
Front Immunol. 2018 Aug 15;9:1838. doi: 10.3389/fimmu.2018.01838. eCollection 2018.

引用本文的文献

1
Optimizing iNKT-driven immune responses against cancer by modulating CD1d in tumor and antigen presenting cells.
Clin Immunol. 2024 Dec;269:110402. doi: 10.1016/j.clim.2024.110402. Epub 2024 Nov 17.
4
Nurses' roles in CAR-T therapy for B-cell malignancies and managing associated cytokine release syndrome.
Asia Pac J Oncol Nurs. 2023 Dec 28;11(2):100367. doi: 10.1016/j.apjon.2023.100367. eCollection 2024 Feb.
5
Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes.
Cancer Rep (Hoboken). 2023 Sep;6 Suppl 1(Suppl 1):e1779. doi: 10.1002/cnr2.1779. Epub 2023 Jan 12.
6
Immunogenic Properties of MVs Containing Structural Hantaviral Proteins: An Original Study.
Pharmaceutics. 2022 Jan 1;14(1):93. doi: 10.3390/pharmaceutics14010093.
7
The Role of STAT1 in T Helper Cell Differentiation during Breast Cancer Progression.
J Breast Cancer. 2021 Jun;24(3):253-265. doi: 10.4048/jbc.2021.24.e34.
8
A snapshot of the PD-1/PD-L1 pathway.
J Cancer. 2021 Mar 5;12(9):2735-2746. doi: 10.7150/jca.57334. eCollection 2021.
10
Infectious Complications of Biological and Small Molecule Targeted Immunomodulatory Therapies.
Clin Microbiol Rev. 2020 Jun 10;33(3). doi: 10.1128/CMR.00035-19. Print 2020 Jun 17.

本文引用的文献

1
Blockade of TGF-beta enhances tumor vaccine efficacy mediated by CD8(+) T cells.
Int J Cancer. 2010 Apr 1;126(7):1666-74. doi: 10.1002/ijc.24961.
2
PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.
Mucosal Immunol. 2010 Jan;3(1):81-91. doi: 10.1038/mi.2009.112. Epub 2009 Sep 9.
4
Invariant natural killer T cells regulate breast cancer response to radiation and CTLA-4 blockade.
Clin Cancer Res. 2009 Jan 15;15(2):597-606. doi: 10.1158/1078-0432.CCR-08-1277.
6
Valpha14 NKT cells activated by alpha-galactosylceramide augment lipopolysaccharide-induced nitric oxide production in mouse intra-hepatic lymphocytes.
Biochem Biophys Res Commun. 2009 Jan 16;378(3):579-83. doi: 10.1016/j.bbrc.2008.11.075. Epub 2008 Dec 3.
10
DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
Immunol Lett. 2007 Dec 15;114(2):86-93. doi: 10.1016/j.imlet.2007.09.008. Epub 2007 Oct 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验